Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert L. Findling, M.D.
University Hospitals Cleveland Medical Center
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Melmed Center
Scottsdale, Arizona, United States
- Bay Area Research Institute
Lafayette, California, United States
- Elite Clinical Trials Inc.
Wildomar, California, United States
- Sarkis Clinical Trials
Gainsville, Florida, United States
- Miami Research Associates
South Miami, Florida, United States
- Northwest Behavioral Research Ctr
Roswell, Georgia, United States
- Mountain West Clinical Trials, Llc
Eagle, Idaho, United States
- Vince and Associates Clinical Research
Overland Park, Kansas, United States
- Shire Clinical Research Site
Lexington, Kentucky, United States
- Four Rivers Clinical Research, Inc.
Paducah, Kentucky, United States
- Rochester Center for Behavioral Medicine
Rochester Hills, Michigan, United States
- Clinical Neurophysiology Services, Pc
Troy, Michigan, United States
- Cri Worldwide
Clementon, New Jersey, United States
- Triangle Neuropsychiatry
Durham, North Carolina, United States
- Dakota Clinic/innovis Health
Fargo, North Dakota, United States
- Odyssey Research
Minot, North Dakota, United States
- University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Oregon Center for Clinical Investigations, Inc.
Eugene, Oregon, United States
- Occi, Inc
Portland, Oregon, United States
- Shire Clinical Research Site
Media, Pennsylvania, United States
- Cri Worldwide
Philadelphia, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Cns Healthcare
Memphis, Tennessee, United States
- Futuresearch Trials
Austin, Texas, United States
- Claghorn-Lesem Research, Ltd.
Bellaire, Texas, United States
- Westex Clinical Investigations
Lubbock, Texas, United States
- Cerebral Research, Llc
San Antonio, Texas, United States
- Vermont Clinical Study Center
Burlington, Vermont, United States
- Neuroscience, Inc.
Herndon, Virginia, United States
- Adolescent Health Center
Midlothian, Virginia, United States
- Northwest Clinical Research Center
Friday Harbor, Washington, United States
- Eastside Therapeutic Resource
Kirkland, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2007
- Primary completion
- 28 Feb 2009
- Completion
- 28 Feb 2009
- Last update posted
- 26 Apr 2017
- Registered enrollment
- 163
- Registry id
- NCT00501293
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.